Back to User profile » Dr Tiantian Tao
Paper published by Dr Tiantian Tao:
Original Research
Cost-Effectiveness of First-Line Zuberitamab-CHOP versus Rituximab-CHOP Regimens in Untreated CD20+ Diffuse Large B-Cell Lymphoma in China
Gao L, Zhu H, Wang J, Lin Y, Ding B, Sun Y, Tao T, Li X
Risk Management and Healthcare Policy 2025, 18:3621-3632
Published Date: 14 November 2025